Tag Archives: European Medicines Agency

Chief medical officer (CMO) Dr Roshan Parasram said that the benefits of taking the Oxford-AstraZeneca vaccine far outweighed the risk of blood clots linked to the vaccine, which he said was rare. “In terms of incidence what they’ve noted in the international population, it’s anywhere between four out of a …

Read More »